Scientific Sessions 2025  /  Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis  /  Development of phosphatidylserine-blocking nanoparticles to inhibit thrombosis
Logo

American Heart Association

  15
  0

Final ID:

Development of phosphatidylserine-blocking nanoparticles to inhibit thrombosis

  • Goldfinger, Lawrence  ( Thomas Jefferson University , Philadelphia , Pennsylvania , United States )
  • Rand, Margaret  ( HOSPITAL SICK CHILDREN , Toronto , Ontario , Canada )
    • Author Disclosures:
    Lawrence Goldfinger: DO NOT have relevant financial relationships | Margaret Rand: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Using Omics to identify novel regulators of platelet activation and thrombosis

Krishnan Anandi, Aslan Joseph

Targeting protein disulfide isomerase (PDI) to prevent thrombosis

Du Xiaoping, Flaumenhaft Robert

You have to be authorized to contact abstract author. Please, Login
Not Available